✦ LIBER ✦

Assessing liver dysfunction in cirrhosis: Role of the model for end-stage liver disease and its derived systems

✍ Scribed by Lee, Yun-Hsuan; Hsu, Chia-Yang; Huo, Teh-Ia

Book ID: 122549161
Publisher: Elsevier Science
Year: 2013
Tongue: Chinese
Weight: 184 KB
Volume: 76
Category: Article
ISSN: 1726-4901
DOI: 10.1016/j.jcma.2013.04.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Defining the severity of liver dysfuncti

Defining the severity of liver dysfunction in patients with hepatocellular carcinoma by the model for end-stage liver disease-derived systems

✍ Yun-Hsuan Lee; Chia-Yang Hsu; Cheng-Yuan Hsia; Yi-Hsiang Huang; Chien-Wei Su; Ha 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 642 KB

Selecting an optimal prognostic system f

Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond

✍ Teh-Ia Huo; Shou-Dong Lee; Han-Chieh Lin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Comparison of four model for end-stage l

Comparison of four model for end-stage liver disease–based prognostic systems for cirrhosis

✍ Teh-Ia Huo; Han-Chieh Lin; Samantha C. Huo; Pui-Ching Lee; Jaw-Ching Wu; Fa-Yauh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB

Serum sodium (Na) has been suggested for incorporation into the Model for End-Stage Liver Disease (MELD) to enhance its prognostic ability for patients with cirrhosis. Three Na-containing models--the Model for End-Stage Liver Disease with the incorporation of serum sodium (MELD-Na), the integrated M

Model for end-stage liver disease, model

Model for end-stage liver disease, model for end-stage liver disease-sodium and Child–Turcotte–Pugh scores over time for the prediction of complications of liver cirrhosis

✍ Pil Cho Choi; Hong Joo Kim; Woo Hyuk Choi; Dong Il Park; Jung Ho Park; Yong Kyun 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Model for end-stage liver disease except

Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score–based liver allocation system

✍ Claire Francoz; Jacques Belghiti; Denis Castaing; Olivier Chazouillères; Jean-Ch 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 1 views

Model for End-Stage Liver Disease (MELD) score-based allocation systems have been adopted by most countries in Europe and North America. Indeed, the MELD score is a robust marker of early mortality for patients with cirrhosis. Except for extreme values, high pretransplant MELD scores do not signific

Clinically relevant differences in the M

Clinically relevant differences in the Model for End-Stage Liver Disease and Model for End-Stage Liver Disease–sodium scores

✍ Rhiana Garritsen; Andrei Tintu; Herold Metselaar; Geert Kazemier 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 1 views

With interest, we read the article by Xiol et al. 1 regarding differences in serum measurements between different laboratories and their influence on the Model for End-Stage Liver Disease (MELD) and the Model for End-Stage Liver Disease incorporating serum sodium (MELD-Na). They reported significant